Erratum to: Mathematical modelling of tumour response in primary breast cancer (British Journal of Cancer, (1996), 73, 11, (1409-1416), 10.1038/bjc.1996.267);Mathematical modelling of tumour response in primary breast cancer

British Journal of Cancer

Volumn 73, Issue 11, 1996, Pages 1409-1416

  Cameron, D A ^a   Gregory, W M ^b   Bowman, A ^a   Leonard, R C F ^a  

^a WESTERN GENERAL HOSPITAL   (United Kingdom)

^b GUY S HOSPITAL   (United Kingdom)

Author keywords

Breast cancer; Mathematical model; Tumour response

Indexed keywords

CYCLOPHOSPHAMIDE; DOXORUBICIN; FLUOROURACIL;

ARTICLE; BREAST CANCER; CANCER COMBINATION CHEMOTHERAPY; CANCER MODEL; CLINICAL ARTICLE; DRUG CYTOTOXICITY; DRUG RESPONSE; FEMALE; HUMAN; HUMAN TISSUE; MATHEMATICAL MODEL; ORAL DRUG ADMINISTRATION; PREDICTION; PRIORITY JOURNAL; TUMOR VOLUME;

EID: 0029946895     PISSN: 00070920     EISSN: 15321827     Source Type: Journal    
DOI: 10.1038/bjc.1997.379     Document Type: Erratum

References (23)

1. BIRKHEAD BG AND GREGORY WM. (1984). A mathematical model of the effects of drug resistance in cancer chemotherapy. Math. Biosci.,72, 59-70.
2. BOWMAN A, COLEMAN R, CHETTY U, DIXON M, GREGORY W, RODGER A AND LEONARD R. (1992). Weekly induction chemotherapy for locally advanced breast cancer. Br. J. Cancer, 65(supp XVI), 32 (abstract p 20).
3. BROWN BW, ATKINSON EN, BARTUSZYNSKI R, THOMPSON JR AND MONTAGUE ED. (1984). Estimation of human tumour growth rate from the distribution of tumour size at detection. J. Natl Cancer Inst., 72, 31-38.
4. ELLEDGE RM, CLARK GM, HON J, THANT M, BELT R, MAGUIRE WP, BROWN J, BARTELLS P AND VON HOFF, DD. (1995). Rapid in vitro assay for predicting response to fluorouracil in patients with metastatic breast cancer. J. Clin. Oncol., 13, 419-423.
5. FOROUHI P, WALSH J, ANDERSON TJ AND CHETTY U. (1994). Ultrasonography as a method of measuring breast tumour size and monitoring response to primary systemic treatment. Br. J. Surg., 81, 223-225.
6. GARDIN G, ALAMA A, ROSSO R, CAMPORA E, REPETTO L, PRONZATO P, MERLIN L, NASO C, CAMORIANO A, MEAZZA R, BARBIERI F, BALDINI E, GIANESSI PG AND CONTE PF. (1994). Relationship of variations in tumour cell kinetics induced by primary chemotherapy to tumour regression and prognosis in locally advanced breast cancer. Breast Cancer Res. Treat., 32, 311-318.
7. GOLDIE JH, COLDMAN AJ AND GUDAUSKAS GA. (1982). Rationale for the use of alternating non-cross resistant chemotherapy. Cancer Treat. Rep., 66, 439-449.
8. GOMPERTZ B. (1825). On the nature of the function expressive of the law of human mortality, and on a new model of determining the value of life contingencies. Phil. Trans. R. Soc. London, 115, 513-585.
9. GREGORY WM, REZNAK RH, HALLETT M AND SLEVIN ML. (1990). Using mathematical models to estimate drug resistance and treatment efficacy via CT scan measurements of tumour volume. Br. J. Cancer, 62, 671-675.
10. HARRIS AL. (1985). DNA repair and resistance to chemotherapy. Cancer Surveys, 4, 601-624.
11. HAYWARD JL, CARBONNE PP, HEUSON JC, KUMAOKA S, SEGALOFF A AND RUBENS RD. (1977). Assessment of response to therapy in advanced breast cancer. Cancer, 39, 1289-1294.
12. HEUSER L, SPRATT J AND POLK H. (1979). Growth rates of primary breast cancer. Cancer, 43, 1888-1894.
13. KOH EH, CHUNG HC, LEE KB, LIM HY, KIM JH, ROH JK, MIN JS, LEE KS AND KIM BS. (1992). The value of immunohistochemical detection of p-glycoprotein in breast cancer before and after induction chemotherapy. Yonsei Med. J., 33, 137-142.
14. LAIRD AK. (1964). Dynamics of tumour growth. Br. J. Cancer, 18, 490-502.
15. LOKICH J, BOTHE A, FINE N AND PERRI J. 1981). Phase I study of protracted venous infusion of 5-fluorouracil. Cancer. 48, 2565-2568.
16. MCCREADY DR, HORTOBAGYI GN, KAN SHU W, SMITH TERRY L. BUZDAR AU AND BALCH Ch.M. (1989). The prognostic significance of lymph node metastases after preoperative chemotherapy for locally advanced breast cancer. Arch. Surg., 124, 21-25.
17. O'SHAUGHNESSY JA AND COWAN KH. (1995). Current status of paclitaxel in the treatment of breast cancer. Breast Cancer Res. Treat., 33, 27-37.
18. PAIN JA, EBBS SR, HERN RPA, LOWE S AND BRADBEER JW. (1992). Assessment of breast cancer size: a comparison of methods. Eur. J. Surg. Oncol., 18, 44-48.
19. PRIORE RL. (1966). Using a mathematical model in the evaluation of human tumor respose to chemotherapy. J. Natl Cancer Inst., 37, 635-647.
20. SKIPPER HE. (1978). Reasons for success and failure in the treatment of murine leukemias with the drugs now employed in treating human leukemias. Cancer Chemotherapy, Vol. 1. University Microfilms International: Ann Arbor, USA.
21. SKIPPER HE, SCHABEL FM JR, AND WILCOX WS. (1964). Experimental evaluation of potential anticancer agents, XIII. On the criteria and kinetics associated with 'curability' of experimental leukemias. Cancer Chemother. Rep., 35, 1-111.
22. VON HOFF DD. 1990). He's not going to talk about in vitro predictive assays again, is he? J. Natl Cancer Inst., 82, 96-101.
23. WARR D, MCKINNEY S AND TANNOCK I. (1984). Influence of measurement error on assessment of response to anticancer chemotherapy: proposal for new criteria of tumour response. J. Clin. Oncol., 2, 1040-1046.